Global Recall of Professional-Use Pregnancy Tests Due to False Positive Risks

Approximately 13 million pregnancy tests intended for professional healthcare use have been recalled globally following reports of false-positive results. The affected devices, manufactured by Innovacon and distributed by Alere, may detect low levels of the hormone hCG in non-pregnant individuals, including those experiencing perimenopause.

The recall impacts facilities in the United States, the United Kingdom, Canada, and several other international markets. While the manufacturer has issued updated instructions to healthcare providers, the specific volume of units distributed within the U.S. market remains undisclosed by both the company and regulatory authorities.

Despite the recall, the manufacturer has advised that the products do not require return and may remain in use if clinicians account for potential false positives during result interpretation. This incident highlights potential gaps in the timely dissemination of medical device safety notices to the public and clinical stakeholders. Regulatory oversight and transparency regarding the distribution of these diagnostic tools remain a point of concern for institutional risk management.